A First in Human Study Consisting of a Two-Part, Double-Blind, Placebo-Controlled, Escalating Single and Multiple Dose Study of VA111913 TS in Adult Non-Pregnant Women Volunteers With a Single Dose, Open, Fed vs. Fasting Crossover Phase.
Phase of Trial: Phase I
Latest Information Update: 07 Oct 2009
At a glance
- Drugs VA 111913 (Primary)
- Indications Dysmenorrhoea
- Focus Adverse reactions; Pharmacokinetics
- 07 Oct 2009 Results were reported in a Vantia Therapeutics media release.
- 26 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Mar 2009 Status changed from recruiting to active, no longer recruiting, according to a Vantia media release.